Speaker
Dr. Alexandra Wyke
Presentation title
Belgium’s Patient Movement: Size and Scope
Presentation outline
She will cover the following topics:
- Evidence of the impact of the empowered patient in Belgium.
- Mapping of the Belgium patient movement.
- Case studies where Belgian patients/patient groups have made an impact on healthcare.
- Ideas about patient-centred in Belgium.
- Strategic ideas about new form of solidarity.
Job title
Doctor Alexandra Wyke, Founder and CEO of PatientView
Biography
Dr Alexandra Wyke is founder and CEO of PatientView an independent, global, research-and-publishing organisation that works closely with patients and health and social campaigning groups worldwide. Between 1996 and April 2000, Alexandra Wyke was responsible for creating and running a successful International healthcare publishing unit at the Economist Intelligence Unit. Between 1983 and 1996, Dr Wyke was the business and science correspondent for The Economist. Aside from her work in The Economist, her other publications include: articles in the Harvard Business Review, the Daily Telegraph, The Economist's The World in 19..; a chapter in Going Digital, and a business report on motivating managers, published by The Economist Group. In 1997, her book, 21st-Century Miracle Medicine, was published by Plenum (see Amazon.com). Dr Wyke frequently lectures and chairs healthcare forums worldwide. She has consulted for stockbrokers, pharmaceutical firms and other organisations. She has worked for television and radio, appearing in an expert capacity in many programmes. In 1996, she was elected by the BBC to participate in a small team, which assessed the corporation's radio and TV coverage of technology. Alexandra Wyke sits on the advisory boards of INSEAD's healthcare initiative, of Avon's Global Woman's Health and Wellness initiative, and of the European Medical Network. Alexandra Wyke has a PhD in biochemistry.
List of publications
A PatientView survey of European and US patient groups, and report into mapped results; commissioned by the EC-funded Eurocancercoms project.
A report by Dr Alexandra Wyke of PatientView, published by The Economist Intelligence Unit; commissioned by Janssen. To unscramble the various perspectives on solving the conundrum facing healthcare financing, PatientView researched the likely shape of healthcare in 2030. http://www.businessresearch.eiu.com/future-healthcare-europe.html-0
A report by Dr Alexandra Wyke of PatientView; commissioned and published by Hill & Knowlton. PatientView interviewed key health technology assessment (HTA) stakeholders, and surveyed 100 patient groups from across Europe on the subject of HTA. The report considers major HTA themes in Europe, and explores patient perceptions of the HTA processes.
http://patientview.posterous.com/who-has-the-say-in-health-technology-assessme
An interactive poster on bipolar disorder, produced by PatientView in collaboration with Michael Berk of the University of Melbourne, Geelong, Victoria, Australia; Guy Goodwin of the University Department, Warneford Hospital, Oxford University, Oxford, UK; and John Tiller of the University of Melbourne, Albert Road Clinic, Melbourne, Victoria, Australia. Commissioned by AstraZeneca.
http://preview.parexel-mms.com/Interactiveposter/zoomPoster_IRBD_47_poster.html
PatientView surveyed English patient groups, patients, and carers, and wrote a reports on the results; commissioned by the National Audit Office (NAO).
http://www.nao.org.uk/publications/0910/stroke.aspx
PatientView surveyed UK patient groups, and wrote a reports on the results; commissioned by the Royal College of Nursing and National Voices.
PatientView surveyed English patient groups, patients, and carers, and wrote a reports on the results; commissioned by the National Audit Office (NAO).
http://www.nao.org.uk/publications/0809/services_for_people_with_rheum.aspx
PatientView surveyed UK patient groups, and wrote a reports on the results; commissioned by the Medicines and Healthcare products Regulatory Agency (MHRA).
http://www.patient-view.com/3.%20Main%20Report%20to%20MHRA%20Public%20Consultation%20with%20Patient%20Representatives,%20Sept%202005.pdf
